the response rates to the recommended strategies have been observed to be high compared to Western data, but 20-40% of patients did not achieve an SVR. [4] [5] [6] Two major predictors of SVR are genotypes and viral load. 3 Other baseline predictors include the doses of Peg/RBV, gender, age, race, body weight, and fibrosis stage. polymorphism is associated with SVR, and SVR rates are doubled in patients with the C/C homozygotes compared with the carrier of the T/T or T/C alleles. The latter two studies have limited value due to small number of patients.
Together with these studies, Lange et al 13 and serum vitamin D levels. 13 Three main findings are as follows. Adding vitamin D to standard interferon therapy may increase SVR rates without serious adverse events. However, to prove these findings, well designed and large prospective studies are needed.
